Herbas VPB

Print
EN | LT
LT - Farmacinės dozavimo formos, kurių sudėtyje yra natrio-1-[6-(morfolin-4-il)pirimidin-4-il]-4-(1H-1,2,3-triazol-1-il)-1H-pirazoil-5-olatas
EN - PHARMACEUTICAL DOSAGE FORMS CONTAINING SODIUM-1-[6-(MORPHOLIN-4-YL)PYRIMIDIN-4-YL]-4-(1H-1,2,3-TRIAZOL-1-YL)-1H-PYRAZOL-5-OLATE

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 9/20 (2006.01)
A61K 9/28 (2006.01)
A61K 31/5377 (2006.01)
A61P 9/04 (2006.01)
A61P 13/12 (2006.01)
A61P 7/06 (2006.01)
European patent
(11) Number of the document 3057580
(13) Kind of document T
(96) European patent application number 14783642.3
Date of filing the European patent application 2014-10-13
(97) Date of publication of the European application 2016-08-24
(45) Date of publication and mention of the grant of the patent 2021-02-24
(46) Date of publication of the claims translation 2021-04-12
PCT application
(86) Number PCT/EP2014/071855
Date 2014-10-13
PCT application publication
(87) Number WO 2015/055564
Date 2015-04-23
Priority applications
(30) Number Date Country code
13189145 2013-10-17 EP
Inventors
(72)
NEUMANN, Heike, DE
BENKE, Klaus, DE
FORMELL, Michael, DE
WINTER, Gabriele, DE
Grantee
(73) Bayer Pharma Aktiengesellschaft, Müllerstrasse 178, 13353 Berlin, DE
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Farmacinės dozavimo formos, kurių sudėtyje yra natrio-1-[6-(morfolin-4-il)pirimidin-4-il]-4-(1H-1,2,3-triazol-1-il)-1H-pirazoil-5-olatas
  PHARMACEUTICAL DOSAGE FORMS CONTAINING SODIUM-1-[6-(MORPHOLIN-4-YL)PYRIMIDIN-4-YL]-4-(1H-1,2,3-TRIAZOL-1-YL)-1H-PYRAZOL-5-OLATE
Last renewal fee
Payment date Validity (years) Amount
2025-09-19 12 289.00 EUR
Next renewal fee
2026-10-13